Your shopping cart is currently empty

Glutaminyl Cyclase Inhibitor 6 (compound BI-43) functions as an inhibitor of both secretory glutaminyl cyclase (sQC) and golgi-resident glutaminyl cyclase (gQC), with IC50 values of 0.012 µM and 0.040 µM, respectively. This compound also holds potential for research in Parkinson's disease.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Glutaminyl Cyclase Inhibitor 6 (compound BI-43) functions as an inhibitor of both secretory glutaminyl cyclase (sQC) and golgi-resident glutaminyl cyclase (gQC), with IC50 values of 0.012 µM and 0.040 µM, respectively. This compound also holds potential for research in Parkinson's disease. |
| In vivo | Compound BI-43, a Glutaminyl Cyclase Inhibitor, administered intraperitoneally at doses of 10, 25, or 40 mg/kg daily for 7 days, has demonstrated efficacy in alleviating motor dysfunction induced by MPTP in various behavioral performance tests. |
| Formula | C27H23N5O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.